Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

An Examination of the Performance of QbMobile in Differential Diagnosis Associated With ADHD Symptoms

NCT: NCT07329673 · RECRUITING

NCT IDNCT07329673
StatusRECRUITING
Start Date2026-01-01
Completion2026-11

Brief Summary

The purpose of this study is to evaluate QbMobile's ability to collect objective data to identify specific symptom profiles in differential diagnoses (ASD, MDD, Bipolar Disorder and Anxiety Disorder) that are common with ADHD.

Frequently Asked Questions

What is An Examination of the Performance of QbMobile in Differential Diagnosis Associated With ADHD Symptoms?

An Examination of the Performance of QbMobile in Differential Diagnosis Associated With ADHD Symptoms is a clinical trial registered under NCT07329673. Current status: RECRUITING.

What is the status of NCT07329673?

The current status of NCT07329673 (An Examination of the Performance of QbMobile in Differential Diagnosis Associated With ADHD Symptoms) is: RECRUITING.

When did An Examination of the Performance of QbMobile in Differential Diagnosis Associated With ADHD Symptoms start?

An Examination of the Performance of QbMobile in Differential Diagnosis Associated With ADHD Symptoms started on 2026-01-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑